Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...
The NHS could start administering a new weight-loss injection as early as March 2025, but eligible patients may have to wait ...
As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...
Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period. The ...
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...